Detected ·
65LAB
——
65LAB awarded US$1.66M funding to advance a potential first-in-class biologic drug for COPD and other inflammatory lung diseases.
- Website
- 65lab.sg
- linkedin.com/company/65lab
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-18 20:05:27 UTC
- Signal ID
- 2aff1cfb-e6d5-4ac2-b28e-f0a2bef27608
As the API returns it
{
"id": "2aff1cfb-e6d5-4ac2-b28e-f0a2bef27608",
"created_at": "2026-05-18T20:05:27.067852Z",
"company_name": "65LAB",
"company_website_url": "65lab.sg",
"company_linkedin_url": "https://www.linkedin.com/company/65lab",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*65LAB awarded US$1.66M funding to advance a potential first-in-class biologic drug for COPD and other inflammatory lung diseases.*"
}